Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ross Tracey

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
British Journal of Pharmacology|March 24, 2004
Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypassHugh Clements-Jewery, Fiona J Sutherland, Mary C Allen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 26, 2002
Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943William P Magee, Gayatri Deshmukh, Michael P Deninno, et al.
European Journal of Pharmacology|November 27, 2002
A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injuryJustin G Chapman, William P Magee, Hans A Stukenbrok, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 16, 2003
Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injuryW Ross Tracey, William P Magee, Joseph J Oleynek, et al.
Cardiovascular Drug Reviews|February 22, 2003
Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1)W Ross Tracey, Mary C Allen, Donald E Frazier, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2007
The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channelTina C Wan, Zhi-Dong Ge, Akihito Tampo, et al.
Cardiovascular Drugs and Therapy|December 31, 2005
The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbitsDavid M Flynn, Andrew H Smith, Judith L Treadway, et al.
European Journal of Pharmacology|September 12, 2002
Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1Ravi B Marala, Janice A Brown, Jimmy X Kong, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptorMichael P DeNinno, Hiroko Masamune, Lois K Chenard, et al.
Journal of Medicinal Chemistry|January 24, 2003
3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptorMichael P DeNinno, Hiroko Masamune, Lois K Chenard, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
British Journal of Pharmacology|March 24, 2004
Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypassHugh Clements-Jewery, Fiona J Sutherland, Mary C Allen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 26, 2002
Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943William P Magee, Gayatri Deshmukh, Michael P Deninno, et al.
European Journal of Pharmacology|November 27, 2002
A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injuryJustin G Chapman, William P Magee, Hans A Stukenbrok, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 16, 2003
Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injuryW Ross Tracey, William P Magee, Joseph J Oleynek, et al.
Cardiovascular Drug Reviews|February 22, 2003
Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1)W Ross Tracey, Mary C Allen, Donald E Frazier, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2007
The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channelTina C Wan, Zhi-Dong Ge, Akihito Tampo, et al.
Cardiovascular Drugs and Therapy|December 31, 2005
The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbitsDavid M Flynn, Andrew H Smith, Judith L Treadway, et al.
European Journal of Pharmacology|September 12, 2002
Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1Ravi B Marala, Janice A Brown, Jimmy X Kong, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptorMichael P DeNinno, Hiroko Masamune, Lois K Chenard, et al.
Journal of Medicinal Chemistry|January 24, 2003
3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptorMichael P DeNinno, Hiroko Masamune, Lois K Chenard, et al.
Pageof 2